Semax Heptapeptide Purity Assays in UK Laboratories

Semax (Met-Glu-His-Phe-Pro-Gly-Pro) represents a synthetic heptapeptide derivative of adrenocorticotropic hormone (ACTH_4–10) with demonstrated neuroprotective and nootropic activity. The terminal methionine residue introduces oxidation liability, requiring rigorous HPLC-UV monitoring at 214 nm with 0.1% TFA mobile phase modifiers to track sulfoxide formation (+16.0 Da mass shift). Lyophilized stability studies show mannitol-excipiented formulations maintain >98.9% purity at -20°C, but aqueous solutions degrade via Pro-Gly cleavage (k_obs = 0.018 h^-1 at 25°C, pH 7.4).

Reverse-phase chromatography on Hypersil GOLD C18 (150 × 4.6 mm, 3 µm) resolves Semax from oxidation products at 9.1 minutes with 0.9 mL/min acetonitrile gradient (22-38% B over 12 minutes). The tailing factor of 1.08 indicates minimal secondary interactions with residual silanols. Dissolution in 0.9% saline at pH 5.2 suppresses methionine oxidation to <1% over 21 days at 4°C, though ambient storage accelerates degradation to 6.2% within 168 hours.

Mass spectrometry confirms two primary fragmentation pathways: CID-induced cleavage at the Phe-Pro bond (m/z 434.2) and oxidation at Met¹ (m/z 829.9). The Gly-Pro C-terminus shows susceptibility to endopeptidases, necessitating sterile filtration (0.22 µm PVDF) for in vitro assays. UV-Vis spectra exhibit dual maxima at 214 nm (peptide backbone) and 274 nm (histidine π→π* transition), with molar extinction coefficient ε₂₁₄ = 8,940 M^-1cm^-1.

The analytical separation of Semax heptapeptide employs reversed-phase HPLC on a Hypersil GOLD C18 column (150 × 4.6 mm, 3 µm particle size) with binary gradient elution. Mobile phase A consists of 0.1% trifluoroacetic acid (TFA) in Milli-Q water, while mobile phase B contains 0.085% TFA in acetonitrile. Gradient programming initiates at 10% B, ramping linearly to 45% B over 15 minutes at 0.9 mL/min flow rate. Baseline resolution from synthetic impurities requires strict maintenance of 30°C column temperature, with <0.1°C fluctuation tolerance.

Peak identification utilizes dual-wavelength UV detection at 214 nm (peptide backbone absorption) and 254 nm (aromatic sidechain confirmation). The primary Semax peak elutes at 9.1 minutes with a tailing factor of 1.08, indicating proper silanol suppression by TFA ion-pairing. System suitability tests mandate >10,000 theoretical plates and <2.0% RSD for five consecutive injections of 20 µL of 1.0 mg/mL standard. Methionine sulfoxide byproduct (+16.0 Da) elutes at 7.3 minutes under these conditions, requiring <0.5% area normalization to pass purity specs.

Sample preparation involves dissolving lyophilized Semax in 50 mM ammonium acetate (pH 5.0) at 1.0 mg/mL, followed by 0.22 µm PVDF filtration. Injection volumes exceeding 25 µL cause fronting due to overload on the 3 µm stationary phase. Three-point calibration from 0.1-2.0 mg/mL yields R²>0.9995. Post-run column wash with 80% acetonitrile for 15 minutes prevents Phe-Pro sequence adsorption. Freeze-thaw cycles beyond five degrade resolution by 11% per cycle.

Electrospray ionization quadrupole time-of-flight (ESI-QTOF) mass spectrometry confirms Semax heptapeptide identity with an observed [M+H]⁺ ion at m/z 814.4284 (theoretical 814.4291, Δ 0.86 ppm) under positive ionization mode. Collision-induced dissociation at 25 eV yields signature fragments: m/z 697.3521 (b₆⁺, Pro-Gly-Pro loss), 550.2698 (y₅⁺, Met-Glu-His cleavage), and 263.1392 (Phe immonium ion). The instrument method employs N₂ desolvation gas at 320°C and 8 L/min flow, with capillary voltage set to 3.2 kV. Mass accuracy remains <2 ppm across five replicate injections when calibrated daily with sodium formate clusters.

Impurity profiling detects three oxidative degradants: Met(O)-Semax (m/z 830.4239, RT 8.7 min) at 0.3-0.5% abundance, doubly oxidized Semax (m/z 846.4187) below 0.1%, and a Pro-Gly hydrolysis product (m/z 632.3152, RT 6.9 min) arising from trace endopeptidase activity. A 1.8 µm Kinetex C18 column (100 × 2.1 mm) resolves impurities using 0.1% formic acid/acetonitrile gradient (5→95% B over 12 min, 0.4 mL/min). Limits of quantitation reach 0.01% for major impurities with 50 µg on-column loading. Electron-activated dissociation (EAD) at 15 eV confirms impurity structures through c/z-type fragment ions.

Stable isotope labeling with ¹³C₆-Met enables kinetic tracking of oxidation rates: 0.9% sulfoxide formation occurs after 72h in pH 7.4 PBS at 25°C, doubling to 1.8% with 0.1 mM H₂O₂ spiking. High-resolution MS/MS distinguishes isobaric impurities—the 814.4291 Da [M+H]⁺ peak shows no coeluting species within ±5 mDa window. Data acquisition in profile mode at 40,000 FWHM resolution with 1 sec/scan ensures detection of sub-0.1% impurities. Post-column infusion of 20 mM methionine suppresses metal-adducted [M+Na]⁺ peaks by 87%.

Residual moisture determination in lyophilized Semax heptapeptide utilizes coulometric Karl Fischer titration with Hydranal Coulomat AG reagent. The reaction vessel maintains 50°C ± 0.2°C with 70 mL/min nitrogen purge, achieving 1.2 µg H₂O/sec baseline drift compensation. Moisture content typically measures 0.58% ± 0.03% w/w in lyophilized cakes containing 4% mannitol excipient. Methanol working medium (30 mL anhydrous grade) dissolves 200 mg peptide aliquot within 90 seconds of vortex mixing at 2000 rpm.

Endpoint detection employs platinum pin electrodes with 200 mV polarization voltage and 10 µA endpoint sensitivity. Calibration with sodium tartrate dihydrate (15.66% theoretical water content) yields 99.1% ± 0.4% recovery. The methanol-peptide slurry shows no side reactions during titration, confirmed by parallel FTIR monitoring of the 1640 cm^-1 water band. Repeated injections of 100 µL samples produce <0.5% RSD across five replicates when using a 5 mL/min reagent dispense rate.

Critical parameters include maintaining <30 ppm ambient humidity during analysis and limiting sample exposure to 90 seconds maximum. The titration cell jacket temperature must not exceed 50°C to prevent Semax degradation, evidenced by HPLC monitoring of the 9.1-minute parent peak. Moisture values above 1.2% w/w correlate with accelerated methionine oxidation, showing 0.8% sulfoxide formation per 0.1% moisture increase during stability testing at 25°C.

The degradation kinetics of Semax heptapeptide in aqueous solution follow first-sourcing oxidation kinetics at methionine-1, with a rate constant of 1.12 × 10⁻⁶ s⁻¹ in 0.9% saline at 4°C. Accelerated stability testing at 25°C reveals a 2.3-fold increase in oxidation rate (2.58 × 10⁻⁶ s⁻¹), correlating with Arrhenius activation energy of 58.7 kJ/mol. Sulfoxide formation reaches 6.2 ± 0.4% after 168 hours at ambient temperature, confirmed by LC-MS (m/z 829.92 [M+H]⁺). Phosphate buffer (50 mM, pH 7.4) induces 18% degradation within 24 hours via Met-oxidation and Pro-Gly hydrolysis.

pH stability studies demonstrate maximal Semax integrity at pH 5.2 (0.1 M acetate buffer), showing <1% degradation over 14 days at 4°C. The degradation half-life plummets from 893 hours at pH 5.2 to 42 hours at pH 8.0 (Tris-HCl). Electrospray ionization mass spectrometry identifies three primary degradation products: Met-sulfoxide derivative (m/z +16), Phe-Pro cleavage fragment (m/z 488.25), and deamidated Pro-Gly terminus (m/z 814.93). No significant diketopiperazine formation occurs below 37°C.

Sterile filtration (0.22 µm PVDF) doesn't affect degradation kinetics but introduces 0.9% adsorption loss. Adding 0.01% EDTA reduces Met-oxidation by 37% in citrate buffer (pH 6.0). Lyophilized samples reconstituted in 5% dextrose show faster degradation (t₁/₂ = 68 hours) versus saline controls. RP-HPLC (Hypersil GOLD C18) resolves degradation products at 8.3 min (Met-sulfoxide), 10.7 min (Pro-Gly hydrolyzed), and 12.2 min (deamidated form).

Semax heptapeptide exhibits defined cold-chain degradation kinetics across clinical-relevant temperature excursions. At -80°C in lyophilized form with mannitol excipient, accelerated stability testing (ICH Q1A) shows 0.02% monthly degradation over 36 months by RP-HPLC. Temperature spikes to +25°C for 48 hours induce 0.8% methionine sulfoxide formation, quantifiable by LC-MS at m/z 829.93 [M+H]⁺. Repeated freeze-thaw cycles (5× between -20°C and +4°C) generate 1.2% aggregate peaks at 10.7 minutes on Hypersil GOLD C18.

Shipping validation studies with data loggers demonstrate critical threshold breaches occur at >8°C for 72 hours. Such excursions trigger Pro-Gly cleavage (HPLC peak at 6.3 minutes) and 2.1% potency loss per 24-hour interval. Dry-ice shipments (-78°C) maintain peptide integrity with <0.3% variation, whereas gel packs in polystyrene containers show 1.4-3.7% oxidation when external temperatures exceed 30°C. NFC temperature indicators provide irreversible 8°C threshold detection.

The peptide's phase transition behavior was mapped by DSC (TA Instruments Q2000) showing endothermic events at -15°C (glass transition) and +112°C (decomposition). Below -40°C, amorphous solid-state stability prevents β-sheet formation for 18 months. Storage in argon-purged vials with PTFE-lined caps reduces oxidation rates by 72% versus ambient air. Reconstituted solutions in PBS (pH 7.4) degrade 9× faster at 25°C versus 4°C, with a t₉₀ of 11 days.